RVL Pharmaceuticals plc·4

May 20, 4:25 PM ET

Schaub James 4

4 · RVL Pharmaceuticals plc · Filed May 20, 2022

Insider Transaction Report

Form 4
Period: 2022-05-18
Schaub James
EVP and COO
Transactions
  • Tax Payment

    Ordinary Shares

    2022-05-18$1.40/sh6,273$8,782390,020 total

Documents

1 file
  • 4
    tm2216239-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT